| 000 | 01785 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516110325.0 | ||
| 264 | 0 | _c20130116 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2012-05-431783 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchwamb, Janine | |
| 245 | 0 | 0 |
_aB-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides. _h[electronic resource] |
| 260 |
_bBlood _cNov 2012 |
||
| 300 |
_a3978-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
| 650 | 0 | 4 |
_aCD40 Ligand _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGlucosylceramides _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-4 _xmetabolism |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xmetabolism |
| 650 | 0 | 4 |
_aNitrophenols _xpharmacology |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Antigen, B-Cell _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aSphingolipids _xmetabolism |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 700 | 1 | _aFeldhaus, Valeska | |
| 700 | 1 | _aBaumann, Michael | |
| 700 | 1 | _aPatz, Michaela | |
| 700 | 1 | _aBrodesser, Susanne | |
| 700 | 1 | _aBrinker, Reinhild | |
| 700 | 1 | _aClaasen, Julia | |
| 700 | 1 | _aPallasch, Christian P | |
| 700 | 1 | _aHallek, Michael | |
| 700 | 1 | _aWendtner, Clemens-Martin | |
| 700 | 1 | _aFrenzel, Lukas P | |
| 773 | 0 |
_tBlood _gvol. 120 _gno. 19 _gp. 3978-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2012-05-431783 _zAvailable from publisher's website |
| 999 |
_c22056994 _d22056994 |
||